Real-World safety and effectiveness of evolocumab in primary hypercholesterolemia and mixed dyslipidemia in Saudi Arabia.
Almutairi AR, Alshahrani WA, Alhathlol GK, Alsheikh F, Alakeel A, Al Yami MS, Fouda M, Almohammed OA, Alhamed MS, Hafiz A, Kutbi H, Bagalagel A, Alharbi A, Alaboud M, Aljohani S, Ashram W.
Almutairi AR, et al. Among authors: hafiz a.
Saudi Pharm J. 2024 Dec;32(12):102203. doi: 10.1016/j.jsps.2024.102203. Epub 2024 Nov 4.
Saudi Pharm J. 2024.
PMID: 39697471
Free PMC article.